Preclinical Study Of Trastuzumab Deruxtecan (T-Dxd; Ds-8201A) In Combination With Dna Damage Response Pathway Inhibitors In Her2-Low/Hormone Receptor Negative Breast Cancer Patient-Derived Xenograft Models
Trastuzumab Deruxtecan
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Preclinical Study Of Trastuzumab Deruxtecan (T-Dxd; Ds-8201A) In Combination With Dna Damage Response Pathway Inhibitors In Her2-Low/Hormone Receptor Negative Breast Cancer Patient-Derived Xenograft Models ### Output: Trastuzumab Deruxtecan